Navigation Links
JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
Date:2/2/2012

CHICAGO and BUCHS/AARAU, Switzerland, Feb. 2, 2012 /PRNewswire/ -- Swisslog and JBT Corporation have entered into a partnership agreement to develop and manufacture state-of-the-art AGVs for hospitals.

With this agreement, a new AGV product line will be jointly developed and marketed from 2013 onwards. The alliance further strengthens Swisslog's reputation as a leading provider of logistics solutions for hospitals. JBT will supply all jointly developed AGVs and software products and benefit from Swisslog's extensive sales and service network and its customer base.

"We are enthusiastic about this agreement as it will create the clear market leader for AGV solutions in hospitals," notes Karl Puhringer, Head of Swisslog's Healthcare Solutions division. "The strength of the partnership is the result of JBT being one of the largest AGV companies worldwide and Swisslog's positioning as a leading provider of logistics solutions for hospitals."

"The partnership will leverage the knowledge and expertise of both companies to produce a state-of-the-art AGV product for hospitals," explains John Lee, Vice President of JBT AeroTech Division. "This is a win-win scenario, with JBT supplying all of the jointly developed products and Swisslog leading the sales, project realization and customer support efforts for the hospital market worldwide."

About JBT Corporation

JBT Corporation (NYSE: JBT) is a leading global solutions provider to the food processing and air transportation industries. JBT Corporation designs, manufactures, tests and services technologically sophisticated systems and products for regional and multi-national industrial food processing customers through its JBT FoodTech segment and for domestic and international air transportation customers through its JBT AeroTech segment. JBT Corporation employs approximately 3,300 people worldwide and op
'/>"/>

SOURCE JBT Corporation; Swisslog
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
2. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
3. Luminex Corporation to Present at JP Morgan Healthcare Conference
4. Neogen Corporation Announces 2nd Quarter Results Conference Call
5. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
6. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
7. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
10. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
11. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... City, Ca. (PRWEB) August 28, 2014 ... E3 rating for an alcohol-based hand sanitizer, asks food ... harvest by comparing the hand sanitizer they’re currently using ... Spray . Hand hygiene is critical to fighting cross-contamination ... environment. Best Sanitizers believes there are key criteria ...
(Date:8/28/2014)... Spin-charge converters are important devices in spintronics, an ... charge of electrons but also on their spin ... transformation of electric into magnetic signals and vice ... Sinova from the Institute of Physics at Johannes ... the UK, Prague, and Japan, has for the ...
(Date:8/28/2014)... -- Next month, executives from clinical trial marketing firm BBK Worldwide ... Patient-Centered Clinical Trials 2014 , to be held at ... September 4-5. Patient recruitment experts Bonnie A. Brescia , ... share insights on the benefits of employing an effective patient ... media to mobile apps – can be used to drive ...
(Date:8/28/2014)... Calif. , Aug. 28, 2014  Armetheon, ... on developing novel mid- to late-stage cardiovascular drug ... million in its first round of financing. The ... Investments and Hercules Bioventures with participation from investors ... and pharmaceutical executive, Dr. Larry Hsu , ...
Breaking Biology Technology:Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3A new, tunable device for spintronics 2A new, tunable device for spintronics 3BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... ,ThalesNano Inc. has announced that commencing in October, it ... Chemistry in Flow"., "Flow chemistry has already had ... Jones, Director of Product Management for,ThalesNano Inc. "Still, most ... to start. Enabling these people to run their own ...
... (Nasdaq: MATK ) --,Martek Biosciences Corporation ... sole source supply agreement with Grupo Ricap. Martek ... produced by Grupo Ricap in,Mexico. Grupo Ricap is ... & life,sARA(TM) will initially be available in infant,formula ...
... for immune enhancement during cold & flu season, ... in,Nutrition Reviews (Vol. 66(9):526-531) by Dr. Barry W. Ritz, ... shown,how AHCC impacts the immune response against a number ... from in vivo studies evaluating,the effect of AHCC supplementation ...
Cached Biology Technology:World Leader in Bench Top Flow Chemistry Instruments ThalesNano, Inc. Introduces an 'Industry First' Seminar Series 2Martek to be the Sole Source Supplier of DHA and ARA for Infant Formulas Produced By Grupo Ricap 2Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents 2
(Date:8/28/2014)... Ga. The support of peer groups and ... breastfeeding programs, according to recent University of Georgia ... in the Athens-Clarke County area determined that role ... outcomes of mothers of infants. , "Mothers who ... successful at breastfeeding," said study co-author Alex Anderson, ...
(Date:8/28/2014)... Advocate and Senior Staff Attorney at the Electronic Frontier ... of biometric and mobile commerce experts set to speak ... Tampa, Florida on September 15, ... Rahman, Director, Technology and Strategy at Samsung, and Philippe de ... this year,s event is Mobility at the Crossroads of ...
(Date:8/28/2014)... (Maximizing Access to Research Careers) Program has announced ... of Sports Medicine,s Conference on Integrative Physiology of ... These awards are meant to promote the ... underrepresented groups into the mainstream of the basic ... young scientists at the American College of Sports ...
Breaking Biology News(10 mins):Breastfeeding study shows need for effective peer counseling programs 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
... to control lens development in mice and humans is also ... as neurobiologists of the Max Delbrck Center for Molecular Medicine ... in which they had removed the c-Maf gene in the ... human carriers of a mutant c-Maf gene. People with such ...
... (February 20, 2012) Molecular biologist Ichiro Matsumoto, Ph.D., ... 2012 Ajinomoto Award for Young Investigators in Gustation, awarded ... an outstanding junior scientist who is an emerging leader ... made significant contributions to the understanding of the organization, ...
... on the rise and more than 120 countries now ... right to create a new, specialized global environmental agency, ... a keynote address to government ministers meeting Tuesday in ... Minister of Malaysia and former co-chair of the UN ...
Cached Biology News:The molecular basis of touch sensation 2Create effective new global environmental agency, ministers urged 2Create effective new global environmental agency, ministers urged 3
...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Normal human AB serum, pooled...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Biology Products: